Home › Trial NCT01920269
Intravesical Adjuvant Electromotive Mitomycin-C
- Trial IDNCT01920269
- StatusCompleted
- PhasePhase 2/3
- Study typeInterventional
- SponsorUniversity of Rome Tor Vergata
- Enrollment331
- Start date1994-01
- ConditionsBladder Cancer TNM Staging Primary Tumor (T) Ta · Bladder Cancer TNM Staging Primary Tumor (T) T1 · Bladder Cancer Transitional Cell Grade
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.